Price Monitoring and Resource Unit set up in Karnataka under the aegis NPPA

News: A Price Monitoring and Resource Unit(PMRU) has been set up in Karnataka under the aegis of National Pharmaceutical Pricing Authority(NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. Facts: PMRU: It is a registered society which functions under the direct control and supervision of State Drug Controllers. Functions:  To assist NPPA in monitoring prices… Continue reading Price Monitoring and Resource Unit set up in Karnataka under the aegis NPPA

COVID-19: NPPA sets up drug price monitoring, resource unit in J-K

News:The National Pharmaceutical Pricing Authority (NPPA) has set up price monitoring and resource unit (PMRU) in the Union Territory of Jammu and Kashmir. Facts: PMRU is a registered society which functions under the direct control and supervision of State Drug Controllers. Funding: By the NPPA. Functions:  Help the NPPA and the State Drug Controller in… Continue reading COVID-19: NPPA sets up drug price monitoring, resource unit in J-K

Cabinet approves extension of pharmaceuticals purchase policy

News:The Union Cabinet has approved the extension/renewal of Pharmaceuticals Purchase Policy(PPP). Facts: About the Policy: Pharmaceuticals Purchase Policy(PPP) was approved by the Cabinet in 2013 for a period of five years in respect of 103 medicines manufactured by pharma CPSUs and their subsidiaries. The policy is applicable to purchases by Central/ State Government departments and… Continue reading Cabinet approves extension of pharmaceuticals purchase policy

Manufacturers told to rush rabies vaccines to areas facing shortage

News:National Pharmaceutical Pricing Authority (NPPA) has ordered the manufacturers to supply the anti-rabies vaccines where there is a shortage of these medicines. Facts: About Rabies: Rabies is caused by Ribonucleic Acid(RNA) virus that is present in the saliva of a rabid animal.It is transmitted following a bite of a rabid animal that leads to deposition… Continue reading Manufacturers told to rush rabies vaccines to areas facing shortage

NPPA allows firms to hike prices of knee implants by up to 10 per cent

National Pharmaceutical Pricing Authority(NPPA) has decided to allow knee implant companies to increase the maximum retail price(MRP) of their products by not more than 10% in 2019. Knee implants are devices used to replace parts of damaged knee joints in patients. This development comes two years after the NPPA had first slashed MRPs of knee… Continue reading NPPA allows firms to hike prices of knee implants by up to 10 per cent

Almost 90% slash in prices of nine anti-cancer drugs

National Pharmaceutical Pricing Authority (NPPA) has slashed the prices of 9 non-scheduled cancer drugs by up to 87%.Earlier,in February this year,the government had capped 42 cancer drugs at 30 %. NPPA is an independent body set up in 1997 under Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. Its mandate is to fix/revise controlled bulk… Continue reading Almost 90% slash in prices of nine anti-cancer drugs

Coronary stents to cost more

Drug price regulator,National Pharmaceutical Pricing Authority (NPPA) has approved hike in prices of coronary stents by 4.2%.It was increased after taking into consideration the inflation of the previous year. As per the new prices notified by the NPPA,a bare metal stent (BMS) would now cost Rs 8,261 while the drug eluting stent (DES) will cost… Continue reading Coronary stents to cost more

Most anti-cancer drugs costly despite price cap, says AIDAN

According to All India Drug Action Network (AIDAN),despite the Government’s decision of price capping of 42 anti-cancer drugs most cancer medicines still remain unaffordable to most Indians because there is no curb on profiteering by pharma manufacturers.Profiteering means unfair profit realized by traders by manipulating prices,tax rate adjustment among others. They have said that the… Continue reading Most anti-cancer drugs costly despite price cap, says AIDAN

Plea in court against drug pricing regulator’s move to cap trade margin for cancer medicines

The National Pharmaceutical Pricing Authority (NPPA) decision to cap the maximum trade margin for cancer medicine has been challenged in the Karnataka High Court by a private hospital group. Earlier,National Pharmaceutical Pricing Authority (NPPA) had invoked powers under Drugs (Prices Control) Order, 2013 and brought 42 non-scheduled anti-cancer drugs under price control by capping trade… Continue reading Plea in court against drug pricing regulator’s move to cap trade margin for cancer medicines

Prices slashed for 463 cancer drugs

The National Pharmaceutical Pricing Authority (NPPA) has invoked powers under Drugs (Prices Control) Order,2013 and brought 463 non-scheduled cancer medicines under price control.This will reduce the trage margin of the drug.The trade margin is the difference between the price at which the manufacturers sell to trade and the price that patients pay(maximum retail price). NPPA… Continue reading Prices slashed for 463 cancer drugs